Placental transfer of SARS-CoV-2 antibodies in mother-neonate pairs: a prospective nested cohort study.

Publication date: Jul 01, 2025

Newborns depend on the transfer of IgG across the placenta to acquire protection against pathogens. We assessed the placental transfer of SARS-CoV-2 antibodies, primarily derived from infection, from seropositive pregnant women enrolled in a pregnancy cohort in Kilifi, Kenya. The study was nested within a prospective observational multi-country cohort study. All available paired maternal delivery and cord blood samples were selected. Maternal sera were tested for SARS-CoV-2 receptor binding domain (RBD) IgM/IgG total antibodies using the Wantai assay. For positive samples, maternal and corresponding cord blood samples were tested for SARS-CoV-2 IgG antibodies against the spike (anti-spike) and nucleocapsid proteins (anti-NCP) using ELISA kits from Euroimmun. A total of 492 (56. 1%) out of 877 maternal delivery samples were positive for RBD IgM/IgG total antibodies. Of these, 416 (84. 6%) were seropositive for either anti-NCP IgG, anti-spike IgG antibodies or both. A total of 412 out of 496 (83%) cord blood samples tested positive for either anti-NCP or anti-spike antibodies. The geometric mean ratio was 1. 04 (95% CI: 0. 90, 1. 21), indicating no significant difference between the anti-spike IgG concentration in cord and maternal blood samples. The log-transformed maternal and cord blood anti-spike IgG concentrations showed a weak positive correlation (r = 0. 364, n = 496, p 

Open Access PDF

Concepts Keywords
364n Adult
Antibodies Antibodies, Viral
Euroimmun Antibodies, Viral
Kenya Coronavirus Nucleocapsid Proteins
Women Coronavirus Nucleocapsid Proteins
COVID-19
COVID-19
Efficiency
Female
Fetal Blood
Humans
Immunity, Maternally-Acquired
Immunoglobulin G
Immunoglobulin G
Immunoglobulin M
Immunoglobulin M
Infant, Newborn
Kenya
Maternal-Fetal Exchange
Placenta
Placental transfer
Pregnancy
Pregnancy Complications, Infectious
Prospective Studies
SARS-CoV-2
SARS-CoV-2 antibodies
Seropositivity
Spike Glycoprotein, Coronavirus
Spike Glycoprotein, Coronavirus
spike protein, SARS-CoV-2
Young Adult

Semantics

Type Source Name
disease MESH infection
disease IDO country
disease IDO assay
disease IDO blood
disease MESH Infectious Diseases
pathway REACTOME Reproduction
drug DRUGBANK Indoleacetic acid
disease MESH COVID-19
disease MESH Pregnancy Complications Infectious

Original Article

(Visited 4 times, 1 visits today)